Big Pharma will never solve the world’s health problems because it makes too much money off disease

Wednesday, April 29, 2015
By Paul Martin

by: Jonathan Benson
Wednesday, April 29, 2015

One of the most fraudulent industries in America today, the pharmaceutical drug racket, has very little to do with actually healing people, and everything to do with generating obscene profits for corporate executives and their vast network of drug dispensers. After all, where would Big Pharma be financially if it developed real cures for sick patients who would naturally no longer need pharmaceuticals once they’re healed?

It would be out of business, that’s where — hence the reason why a continuous drug “pipeline” regularly spews out new drugs to treat diseases but not actually cure any of them. It’s common sense, really, from a business perspective. But it’s something that many people fail to recognize in the vast, for-profit medicine model that dominates not only the West, but increasingly many nations in the developing world.

Just think about it for a minute: something like Susan G. Komen’s “Race for the Cure,” for instance, a multi-billion-dollar nonprofit organization that’s supposedly looking for a cure for breast cancer. If it ever actually found a cure for breast cancer, Komen’s endless funding stream would immediately dry up, and its president and CEO Dr. Judith Salerno would no longer be putting away nearly half a million dollars a year in salary and benefits.

This is pittance compared to what drug industry CEOs make, of course. Manufacturing pharma pills that maim and kill people while convincing regulatory agencies to approve them as medicine is hard work, apparently. So boards of directors don’t seem to mind rewarding the captains of their death ships with sizable compensation packages that include hefty bonuses, personal jets and other lavish perks.

The Rest…HERE

Leave a Reply

Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter